Abstract
Peptides and proteins are currently emerging as a major class of future drugs. So far the research in this field is mainly focused on basic research covering isolation, synthesis, analysis, and biological and clinical effects. However, increasing attention is now also given to considerations regarding suitable dosage forms and routes of absorption. It is widely accepted that the most common dosage forms and routes, i.e. solid dosage forms for peroral application and sterile preparations for parenteral application, will not provide a realistic basis for a widespread use of these drugs in the future. This is because (i) most oligopeptides and proteins are not readily absorbed in the gastrointestinal tract, e.g. due to the presence of proteolytic enzymes and the low permeability of the gut membranes to such often hydrophilic compounds. And also (ii) parenteral application, certainly, is of limited suitability to long term treatments and frequent use of drugs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anders, R., Merkle, H.P., Schurr, W., Ziegler, R., 1983, Buccal Absorption of protirelin: an effective way to stimulate thyrotropin and prolactin, J. Pharm. Sci., 72: 1481.
Anders, R., 1984, Ph.D. Thesis: Selbsthaftende Polymerfilme zur bukkalen Applikation von Peptiden, Universität Bonn, Bonn.
Anders, R., and Merkle. H.P., 1986, Arzneiformung selbsthaftender Polymerfilme zur bukkalen Applikation, manuscript in preparation.
Bergjoe, P., and Jenssen, H., 1969, Nasal and buccal oxytocin for the introduction of labour: a clinical trial, J. Obstet. Gynaec. Brit. Cwlth., 76: 131.
Chien, Y.W., ed., 1985, Transnasal Systemic Medications, Elsevier, Amsterdam.
Chien, Y.W., and Chang, S.F., 1985, Historic development of transnasal systemic medications, in: “Transnasal systemic medications”, Y.W. Chien, ed., Elsevier, Amsterdam, 1.
Ch’ng, H.S., Park, H., Kelly, P., and Robinson, J.R., 1985, Bioadhesive polymers as platforms for oral controlled drug delivery II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers, J. Pharm. Sci., 74: 399.
Davis, S.S., Daly, P.B., Kennerley, J.W., Frier, M., Hardy, J.G., and Wilson, C.G., 1982, Design and evaluation of sustained release formulations for oral and buccal administration, in: “Controlled release nitroglycerin in buccal and oral form”, W.-D. Bussmann, R.-D. Dries, and W. Wagner, eds., Advances in Pharmacotherapy, Vol. 1, Karger, Basel, 17.
Davis, S.S., 1985, personal communication.
Ishida, M., Machida, Y., Nambu, N., and Nagai, T., 1981, New mucosal dosage form of insulin, Chem. Pharm. Bull., 29: 810.
Ishida, M., Nambu, N., Nagai, T., 1982, Mucosal dosage form of lidocain for toothache using hydroxypropyl cellulose and carbopol, Chem. Pharm. Bull., 30: 980.
Hussain, A.A., Bawarshi-Nassar, R., Huang, C.H., 1985, Physicochemical considerations in intranasal drug administration, in: “Transnasal systemic medications”, Y.W. Chien, ed., Elsevier, Amsterdam, 121.
Lee, P., 1986, Kinetics of drug release from hydrogel matrices, in: “Advances in drug delivery systems”, J.M. Anderson and S.W. Kim, eds., Elsevier, Amsterdam, 277.
Merkle, H.P., Anders, R., Sandow, J., Schurr, W., 1985, Self-adhesive patches for buccal delivery of peptides, Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 12: 85.
Merkle, H.P., Anders, R., and Sandow, J., 1986, Abstract: Buccal Absorption of peptides in rats, Proceed. 32th annual congress of APV, Mainz, 57.
Nagai, T., 1986, Adhesive topical drug delivery systems, in: “Advances in drug delivery systems”, J.M. Anderson, S.W. Kim, eds., Elsevier, Amsterdam, 121.
Nishi, N., Arimura, A., Coy, D.H., Vilches-Martinez, J.A., Schally, A.V., 1975, The effect of oral and vaginal administration of synthetic LHRH and (D-Ala(6)-DesGly(10)-NH)-LHRH ethylamid on serum LH-levels on ovariectomized, steroid blocked rats, Proc. Soc. Exp. Biol. Med., 148: 1009.
Nishihata, T., Rytting, J.H., Higuchi, T., Caldwell, L., 1981, Enhanced rectal absorption of insulin and heparin in rats in the presence of non-surfactant adjuvants, J. Pharm. Sci., 33: 334.
Okada, H., Yamazaki, I., Ogawa, Y., Hirai, S., Yashiki, T., Mima, H., 1982, Vaginal absorption of a potent luteinizing hormone-releasing analogue (Leuprolide) in rats I: absorption by various routes and absorption enhancement, J. Pharm. Sci., 71: 1367.
Okada, H., Yamazaki, I., Yashiki, T., Mima, H., 1983, Vaginal absorption of a potent luteinizing hormone-releasing analogue (Leuprolide) in rats II: mechanism of absorption enhancement, J. Pharm. Sci., 72: 75.
Park, H., and Robinson, J.R., 1986, Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion, in: “Advances in drug delivery systems”, J.M. Anderson, and S.W. Kim, eds., Elsevier, Amsterdam, 47.
Peppas, N.A., and Buri, P.A., 1986, Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues, in: “Advances in drug delivery systems”, J.M. Anderson, and S.W. Kim, eds., Elsevier, Amsterdam, 257.
Sandow, J., and Petri, W., 1985, Intranasal administration of peptides biological activity and therapeutic efficacy, in: “Transnasal Systemic Medications”, Y.W. Chien, ed., Elsevier, Amsterdam, 183.
Schurr, W., Knoll, B., Ziegler, R., Anders, R., and Merkle, H.P., 1985, Comparative study of intravenous, nasal, oral and buccal TRH administration among healthy subjects, J. Endocrin. Invest., 8: 41.
Stratford, R.E., and Lee, V.H.L., 1985, Aminopeptidase activity in albino rabbit extraocular tissues relative to the small intestine, J. Pharm. Sci, 74: 731.
Su, K.S.E., 1986, Intranasal delivery of peptides and proteins, Pharm. Int., 7: 8.
Su, K.S.E., and Campanale, K.M., 1985, Nasal drug delivery systems requirements, development and evaluations, in: “Transnasal Systemic medications”, Y.W. Chien, ed., Elsevier, Amsterdam, 139.
Van de Donk, H.J.M., Van den Heuvel, A.G.M., Zuidema, J., and Merkus, F.W. H.M., 1982, The effects of nasal drops and their additives on human, nasal mucociliary clearance, Rhinology, 20: 127.
Wespi, H.J., and Rehsteiner, H.P., 1966, Erfahrungen mit Syntocinon-und ODA-Buccaltabletten, Gynaecologia, 162: 414.
Yoshioka, S., Caldwell, L., and Higuchi, T., 1982, Enhanced rectal bioavailability of polypeptides using sodium 5-methoxysalicylate as an absorption promotor, J. Pharm. Sci., 71: 593.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Merkle, H.P., Anders, R., Sandow, J., Schurr, W. (1986). Drug Delivery of Peptides: The Buccal Route. In: Davis, S.S., Illum, L., Tomlinson, E. (eds) Delivery Systems for Peptide Drugs. NATO ASI Series, vol 125. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9960-6_13
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9960-6_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9962-0
Online ISBN: 978-1-4757-9960-6
eBook Packages: Springer Book Archive